What does CUSIP 590328209 represent in this 13F holders report?

CUSIP 590328209 is the security identifier for MACK - MERRIMACK PHARMACEUTICALS IN - COM NEW used to aggregate holder disclosures.

How many institutions held MACK - MERRIMACK PHARMACEUTICALS IN - COM NEW in Q1 2025?

No institutional holders were reported for MACK - MERRIMACK PHARMACEUTICALS IN - COM NEW in Q1 2025; review adjacent reporting periods for trend context.

MERRIMACK PHARMACEUTICALS IN - COM NEW (MACK)

CUSIP: 590328209

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class: Equity / COM NEW
Total 13F shares: 0
Share change: -24,500
Total reported value: $0
Number of holders: 0
Value change: -$370,685
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 590328209?
CUSIP 590328209 identifies MACK - MERRIMACK PHARMACEUTICALS IN - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q4 2024

Recent filing periods for CUSIP 590328209:

Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023

MERRIMACK PHARMACEUTICALS IN - COM NEW (MACK)

Q1 2025 13F Holders as of 31 Mar 2025

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of MACK - MERRIMACK PHARMACEUTICALS IN - COM NEW as of Q1 2025.